Monday, July 30, 2018 Daily Archives

The DeltaV™ PK Controller: Powerful Standalone — Easily Integrated

by

The PK Controller brings ground-breaking innovation and technology that is powerful standalone for small units and easily integrates into a plant-wide DCS. With faster logic execution, built-in native Ethernet ports and native device protocols, the DeltaV™ PK Controller addresses a wide variety of applications and system sizes. The fit-for-purpose controller enables you to have a single native database and system allowing you to shorten project schedule and accommodate late changes. What is Powerful Standalone? Operate and configure your standalone applications…

July 30, 2018

Lonza: CAR-T Manufacturing Glitch an Industry Problem, not Just Novartis’s

by

Novartis has reported issues around the manufacture of Kymriah (tisagenlecleucel). With CAR-T being a new field, teething problems are normal, says CDMO Lonza. In August 2017, Novartis became the first company to receive US Food and Drug Administration (FDA) approval for a chimeric antigen receptor (CAR) T-cell therapy. But during its Q2 results, the Swiss Biopharma admitted some issues in the manufacturing of the therapy for its diffuse large B-cell lymphoma (DLBCL) indication. “We have seen some variability in our…

July 30, 2018

Bioproduction: A ‘Tale of Two Facilities,’ Says Jacobs

by

The advent of single-use bioreactors has revolutionized facility design says Jacobs, which has worked in the biomanufacturing sector for almost 30 years. As the biotech industry matured in the 1990s, Jacobs Engineering acquired Triad Technologies and Sigel Group to expand its expertise in designing and constructing biotechnology facilities. The firm has since been involved in many of the most prominent biomanufacturing facilities over the past few decades, working on Schering-Plough’s (now Merck & Co.) facility in Tuas, Singapore; Bristol-Myers Squibb’s…

July 30, 2018